Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a ...
Medical Xpress on MSN5d
First-ever randomized clinical trial uses video telehealth for suicide preventionIn 2022, there were 49,449 suicides in the United States. The randomized clinical trial of 96 U.S. adults with recent ...
Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...
An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...
There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...
The two-day event will see industry experts from across the clinical trial space holding talks on subjects from AI to ...
Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of ...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...
November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback